The role of positron emission tomography in management of small cell lung cancer

被引：32
|
作者：
Thomson, D. [1 ]
Hulse, P. [2 ]
Lorigan, P. [3 ]
Faivre-Finn, C. [1 ]
机构：
[1] Christie NHS Fdn Trust, Dept Clin Oncol, Manchester M20 4BX, Lancs, England
[2] Christie NHS Fdn Trust, Dept Radiol, Manchester M20 4BX, Lancs, England
[3] Christie NHS Fdn Trust, Dept Med Oncol, Manchester M20 4BX, Lancs, England
来源：
LUNG CANCER | 2011年 / 73卷 / 02期
关键词：
Lung cancer; Small-cell lung cancer; Positron emission tomography; PET; FDG-PET; PET-CT; CLINICAL-PRACTICE GUIDELINES; PHASE-III TRIAL; BODY FDG-PET; RESPONSE EVALUATION; THORACIC RADIOTHERAPY; TNM-CLASSIFICATION; PROGNOSTIC-FACTORS; F-18-FDG PET; DIAGNOSIS; CT;
D O I：
10.1016/j.lungcan.2011.03.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Accurate radiological staging of small-cell lung cancer (SCLC) is of paramount importance in selection of individual patients with limited stage disease for potentially curative treatment while avoiding toxic treatment in those with distant metastatic disease. [F-18] flurodeoxy-o-glucose (FDG) positron emission tomography (PET) is an attractive tool for this purpose but there is limited evidence to support its use in the routine staging of SCLC. Whether therapeutic decisions based on FDG-PET imaging should be made remains uncertain. There is only preliminary evidence for use of FDG-PET as a prognostic biomarker, in the assessment of response to treatment and delineation of disease in conformal radiation planning. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：121 / 126
页数：6
相关论文
共 50 条
  • [21] The role of positron emission tomography in the management of pancreatic cancer
    Pakzad, Farrokh
    Groves, Ashley M.
    Ell, Peter J.
    SEMINARS IN NUCLEAR MEDICINE, 2006, 36 (03) : 248 - 256
  • [22] Role of positron emission tomography in the management of breast cancer
    Smith, IC
    Gilbert, FJ
    BREAST, 1999, 8 (06): : 303 - 310
  • [23] The role of positron emission tomography in the diagnosis, staging and response assessment of non-small cell lung cancer
    Volpi, Sara
    Ali, Jason M.
    Tasker, Angela
    Peryt, Adam
    Aresu, Giuseppe
    Coonar, Aman S.
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (05)
  • [24] The role of positron emission tomography in mediastinal lymph node staging of non-small-cell lung cancer
    Melek, Huseyin
    Kavakli, Kuthan
    Gunluoglu, M. Zeki
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2011, 19 (03): : 480 - 481
  • [25] The Role Of Positron Emission Tomography - Computed Tomography (PET/CT) In The Prognosis Of Patients With Non Small Cell Lung Cancer (NSCLC)
    Tesfaye, A.
    Mozayen, M.
    Sarangi, M.
    Nagpal, S.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S295 - S295
  • [26] The relevance of positron emission tomography response in non-small cell lung cancer
    Tufman A.
    Müller-Lisse U.
    Reu S.
    Huber R.M.
    Berger F.
    memo - Magazine of European Medical Oncology, 2015, 8 (2) : 119 - 129
  • [27] The value of positron emission tomography in patients with non-small cell lung cancer
    Kee, Frank
    Erridge, Sara
    Bradbury, Ian
    Cairns, Karen
    EUROPEAN JOURNAL OF RADIOLOGY, 2010, 73 (01) : 50 - 58
  • [28] Positron emission tomography in the staging of small-cell lung cancer - A preliminary study
    Hauber, HP
    Bohuslavizki, KH
    Lund, CH
    Fritscher-Ravens, A
    Meyer, A
    Pforte, A
    CHEST, 2001, 119 (03) : 950 - 954
  • [29] The role of positron emission tomography in germ cell cancer
    Maria De Santis
    Jörg Pont
    World Journal of Urology, 2004, 22 : 41 - 46
  • [30] The association of metabolic positron emission tomography/computed tomography parameters with survival in small cell lung cancer
    Turk, Merve Ayik
    Komurcuoglu, Berna
    Aguloglu, Nursin
    Ciftci, Tugce Doksoz
    Fidan, Mucahit
    Colak, Sinan
    Batum, Ozgur
    ANNALS OF SAUDI MEDICINE, 2025, 45 (01) : 25 - 32
12345